药物性肝损伤、药物诱导性自身免疫性肝炎和自身免疫性肝炎鉴别诊断研究进展*

doi:10.3969/j.issn.1672-5069.2021.04.002

Abstract

Li Bianli, Xu Lihong. Differential diagnosis of drug-induced liver injury, drug-induced autoimmune hepatitis and autoimmune hepatitis[J]. Journal of Practical Hepatology, 2021, 24(4): 460-463.

[1] 于乐成,茅益民,陈成伟.药物性肝损伤诊治指南.肝脏,2015,20(10):750-767.
[2] Bjornsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology, 2010, 51(6): 2040-2048.
[3] 自身免疫性肝炎诊断和治疗共识(2015).肝脏,2015,20(12):969-982.
[4] 曹亦楠,周桂琴,王宪波,等.自身免疫性肝炎发病机制的研究现状.临床肝胆病杂志,2019,35(10):2335-2338.
[5] Yeong TT, Lim KH, Goubet S, et al. Natural history and outcomes in drug-induced autoimmune hepatitis. Hepatol Res,2016,46(3): E79-88.
[6] Martinez-Casas OY, Diaz-Ramirez GS, Marin-Zuluaga JI, et al. Differential characteristics in drug-induced autoimmune hepatitis. JGH Open,2018,2(3):97-104.
[7] Shehu AI, Ma X, Venkataramanan R. Mechanisms of drug-induced hepatotoxicity. Clin Liver Dis,2017,21(1):35-54.
[8] Ju C. Immunological mechanisms of drug-induced liver injury. Curr Opin Drug Discov Devel, 2005,8(1): 38-43.
[9] Pirmohamed M, Naisbitt DJ, Gordon F, et al. The danger hypothesis—potential role in idiosyncratic drug reactions. Toxicology,2002,181-182:55-63.
[10] Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol,2002,2(4):301-305.
[11] 宋娟,闫晓君,张迎.药物性肝损伤的临床特点及影像学特征分析.中华灾害救援医学,2019,7(12):678-681.
[12] Ortega-Alonso A, Andrade RJ. Chronic liver injury induced by drugs and toxins. J Dig Dis,2018,19(9):514-521.
[13] Malik N,Venkatesh SK. Imaging of autoimmune hepatitis and overlap syndromes. Abdom Radiol(NY),2017, 42(1):19-27.
[14] 刘靓懿,宿冬远.药物性肝损伤与自身免疫性肝炎临床和肝组织病理学特征比较研究.实用肝脏病杂志,2018,21(3):463-464.
[15] Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol,1993,46(11):1323-1330.
[16] Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis:a retrospective analysis. Hepatology,2002,35(4):890-897.
[17] Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology,1993,18(4):998-1005.
[18] Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Groupreport: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol,1999,31(5):929-938.
[19] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology,2008,48(1):169-176.
[20] Timur L, Christoph S. Autoimmune hepatitis-update on clinical management in 2017. Clin Res Hepatol Gastroenterol,2017,41(6):617-625.

Differential diagnosis of drug-induced liver injury, drug-induced autoimmune hepatitis and autoimmune hepatitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Wang Qixia, Ma Xiong. Insights to precision medicine and clinical translational research in patients with autoimmune liver diseases [J]. Journal of Practical Hepatology, 2021, 24(4): 457-459.
[2]	Liang Yuping, Su Quanqiu, Zhang Hui, et al. Serum vitamin D deficiency in patients with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2021, 24(4): 464-467.
[3]	Liu Na, Zhang Huamin, Deng Qiaojuan. Impact of inhibition of TRAF6 gene expression on hepatic NF-κB-related protein expression in rats with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2021, 24(4): 468-471.
[4]	Lu Xiaolong, Xie Chunbao. Implication of IL-6 gene polymorphism in short-term prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2021, 24(4): 516-519.
[5]	Zhang Bing, Chen Ruihong, Yang Wei, et al. Application of serum HSP90α and PIVKA-II levels in prognosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(4): 548-551.
[6]	Wang Tingting, Xin Yang, Wang Nana. Expression of CBX7 and PERK incancerous tissues in patients with hepatocellular carcinoma and its implication of prognosis after hepatectomy [J]. Journal of Practical Hepatology, 2021, 24(4): 552-555.
[7]	Yu Zhe, Luo Jing, Yang Yongping. Peripheral blood mononuclear cell GPSM2 levels might be a new marker for prognosis of patients with hepatocellular carcinoma stage III [J]. Journal of Practical Hepatology, 2021, 24(4): 556-560.
[8]	Yu Tao, Li Kuiwu, Yao Lin, et al. Implication of ubiquitinase E2T expression in cancerous tissues in patients with gallbladder cancer [J]. Journal of Practical Hepatology, 2021, 24(4): 593-596.
[9]	Wang Mengyu, Yang Ruixu, Fan Jiangao. Clinical feature and outcomes of patients with metabolic associated fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 308-311.
[10]	Chen Chen, Wang Lianfa, Wang Yan, et al. Serum liver and kidney function tests and myocardial enzymes in 112 patients with coronavirus-19 pneumonia [J]. Journal of Practical Hepatology, 2021, 24(3): 351-354.
[11]	Qi Mei, Zhang Ruijin, Tian Shuping, et al. Impacting factors in response to immunosuppressive therapy in patients with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2021, 24(3): 371-374.
[12]	Huang Chunyang, Chen Jie, Zhang Xiaodan, et al. Serum ALT/ALP ratio changes and histopathological features of patients with drug-induced liver injury acute hepatocellular type [J]. Journal of Practical Hepatology, 2021, 24(3): 379-382.
[13]	Liu Songtao, Meng Qinghua, Lyu Jun, et al. Clinical feature and prognosis of lymphoma patients with chemotherapy-induced liver failure [J]. Journal of Practical Hepatology, 2021, 24(3): 383-386.
[14]	Kong Xuejie, Li Jiang, Li Haotian, et al. Clinical feature and efficacy of different prognostic scoring models in patients with acute-on-chronic liver failure with different underlying liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 387-390.
[15]	Su Yayong, Xu Chengrun, Guo Yongmu, et al. Risk factors of death in patients with hepatitis B virus-related acute on chronic liver failure [J]. Journal of Practical Hepatology, 2021, 24(3): 391-394.